Brad Hively's Insider Trades & SAST Disclosures
Brad Hively's most recent trade in Oncology Institute Inc (The) was a trade of 44,000 Common stock done . Disclosure was reported to the exchange on Nov. 22, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brad Hively.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc (The) | Brad Hively | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 44,000 | 720,203 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Brad Hively | Director | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 353,450 | 366,753 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Brad Hively | Director | Purchase of securities on an exchange or from another person at price $ 0.17 per share. | 12 Nov 2024 | 250,000 | 616,753 | - | 0.2 | 42,500 | Common stock |
| Oncology Institute Inc (The) | Brad Hively | Director | Purchase of securities on an exchange or from another person at price $ 0.15 per share. | 12 Nov 2024 | 50,000 | 666,753 | - | 0.2 | 7,500 | Common stock |
| Oncology Institute Inc (The) | Brad Hively | Director | Sale or transfer of securities back to the company at price $ 0.46 per share. | 17 Jun 2024 | 18,121 | 676,203 | - | 0.5 | 8,296 | Common Stock |
| Oncology Institute Inc (The) | Brad Hively | Director | Sale or transfer of securities back to the company at price $ 0.58 per share. | 22 May 2024 | 19,526 | 694,324 | - | 0.6 | 11,233 | Common Stock |
| Oncology Institute Inc (The) | Hively Brad | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 42,652 | 713,850 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Brad Hively | Director | Sale or transfer of securities back to the company at price $ 2.19 per share. | 21 Nov 2023 | 25,867 | 671,198 | - | 2.2 | 56,726 | Common stock |
| Oncology Institute Inc (The) | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. | 17 Nov 2023 | 25,000 | 722,065 | - | 0.9 | 21,250 | Common stock |
| Oncology Institute Inc (The) | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2023 | 25,000 | 1,745,431 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Brad Hively | Director | Sale of securities on an exchange or to another person at price $ 2.24 per share. | 17 Nov 2023 | 25,000 | 697,065 | - | 2.2 | 56,000 | Common stock |
| Oncology Institute Inc (The) | Brad Hively | Director | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 13 Nov 2023 | 47,000 | 724,182 | - | 2.5 | 118,581 | Common stock |
| Oncology Institute Inc (The) | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2023 | 47,000 | 1,770,431 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. | 13 Nov 2023 | 47,000 | 771,182 | - | 0.9 | 39,950 | Common stock |
| Oncology Institute Inc (The) | Brad Hively | Director | Sale or transfer of securities back to the company at price $ 2.39 per share. | 13 Nov 2023 | 27,117 | 697,065 | - | 2.4 | 64,755 | Common stock |
| Oncology Institute Inc (The) | Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 421,280 | 421,280 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 168,512 | 724,182 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Brad Hively | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 525,188 | 525,188 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Brad Hively | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 103,469 | 555,670 | - | 0 | Common Stock | |
| Oncology Institute Inc (The) | Brad Hively | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 15 Nov 2022 | 9,718 | 452,201 | - | 2.0 | 19,706 | Common Stock |
| Oncology Institute Inc (The) | Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 550,563 | 550,563 | - | - | Stock Option (right to buy) | |
| Oncology Institute Inc (The) | Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 212,070 | 363,450 | - | 0 | Common Stock | |
| Oncology Institute Inc (The) | Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 141,380 | 141,380 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges